Skip to main content
FLNASector not reported

FILANA THERAPEUTICS, INC. (FLNA) Insider Trading

In the last 90 days, 1 FILANA THERAPEUTICS, INC. (FLNA) insider reported 2 open-market purchases totaling $356,322 and no sales. The most recent open-market purchase was reported on Sep 30, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$356,322
Corporate buyers
1
Latest transaction
Sep 30, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 30, 2026Richard BarryPresident & CEOOpen Market Purchase306,813$0.91$278,126
Sep 28, 2026Richard BarryPresident & CEOOpen Market Purchase93,091$0.84$78,196

Common questions

FLNA insider trading FAQ

Are FLNA insiders buying or selling?
Over the last 90 days, FLNA insiders were net buyers, reporting $356,322 of open-market purchases and $0.00 of sales.
When was the last FLNA insider purchase?
The most recent open-market purchase of FILANA THERAPEUTICS, INC. stock by an insider was reported on Sep 30, 2026, one of 2 purchases in the last 90 days.
Where does FLNA insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that FILANA THERAPEUTICS, INC. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.